ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

‘Immunotherapy’ in Monkeys Shows Promise as Long-Term HIV Treatment – Philly.com

Continue reading

2017-03-13 Michael Zand NEWS

Exploring Immunotherapy Combos in Breast Cancer – Curetoday.com


International Business Times UK

‘Immunotherapy‘ in Monkeys Shows Promise as Long-Term HIV Treatment
Philly.com
“It works by taking advantage of the immune system’s natural defenses, similar to what happens in some forms of cancer immunotherapy,” he said in a university news release. The researchers used a model of HIV infection that affects macaque monkeys.
Early intervention with new treatment provides durable control of HIV …The Rockefeller University Newswire
Two potent antibodies help monkeys fight HIV – in the long runInternational Business Times UK

all 5 news articles »

Continue reading

2017-03-13 Michael Zand NEWS

‘Immunotherapy’ in Monkeys Shows Promise as Long-Term HIV Treatment – U.S. News & World Report


Curetoday.com

Exploring Immunotherapy Combos in Breast Cancer
Curetoday.com
In multiple ongoing clinical trials, immunotherapy combinations are proving their power as a potential treatment option for patients wit breast cancer, according to Elizabeth A. Mittendorf, M.D., Ph.D., who spoke about the topic at the 2017 Miami …
Combinations ‘Likely the Way Forward’ for Breast Cancer Immunotherapy ResearchCancer Network

all 2 news articles »

Continue reading

2017-03-13 Michael Zand NEWS

‘Immunotherapy’ in Monkeys Shows Promise as Long-Term HIV Treatment – HealthDay


The Rockefeller University Newswire

‘Immunotherapy‘ in Monkeys Shows Promise as Long-Term HIV Treatment
U.S. News & World Report
MONDAY, March 13, 2017 (HealthDay News) — Lab experiments with monkeys suggest that “immunotherapy” holds promise as a long-term treatment for HIV, researchers say. Treatment with two anti-HIV antibodies right after infection might help keep the …
Early intervention with new treatment provides durable control of HIV-like virus in monkeysThe Rockefeller University Newswire
Two potent antibodies help monkeys fight HIV – in the long runInternational Business Times UK

all 5 news articles »

Continue reading

2017-03-13 Michael Zand NEWS

Combinations ‘Likely the Way Forward’ for Breast Cancer Immunotherapy Research – Cancer Network


HealthDay

‘Immunotherapy‘ in Monkeys Shows Promise as Long-Term HIV Treatment
HealthDay
MONDAY, March 13, 2017 (HealthDay News) — Lab experiments with monkeys suggest that “immunotherapy” holds promise as a long-term treatment for HIV, researchers say. Treatment with two anti-HIV antibodies right after infection might help keep the …

Continue reading

2017-03-13 Michael Zand NEWS

The Chiropractor’s Guide to CRISPR – Dynamic Chiropractic

Combinations ‘Likely the Way Forward’ for Breast Cancer Immunotherapy Research
Cancer Network
Despite breast tumors’ lower mutational loads than lung cancers and melanoma—cancers in which immunotherapy have shown particular promise—breast cancers are nevertheless immunogenic, Elizabeth A. Mittendorf, MD, PhD, of the University of Texas …

and more »

Continue reading

2017-03-13 Michael Zand NEWS

Combinations ‘Likely the Way Forward’ for Breast Cancer Immunotherapy Research – Cancer Network

The Chiropractor’s Guide to CRISPR
Dynamic Chiropractic
Science magazine’s “Breakthrough of the Year” award for 2015 was described as “the gene-editing tool called CRISPR.”1CRISPR stands for “clustered regularly interspaced short palindromic repeats.” It is very likely that this will not only replace …

Continue reading

2017-03-13 Michael Zand NEWS

Pain in the neck: Engineers use CRISPR technology to prevent tissue damage, resulting chronic pain – Science Daily


Targeted Oncology

Combinations ‘Likely the Way Forward’ for Breast Cancer Immunotherapy Research
Cancer Network
Despite breast tumors’ lower mutational loads than lung cancers and melanoma—cancers in which immunotherapy have shown particular promise—breast cancers are nevertheless immunogenic, Elizabeth A. Mittendorf, MD, PhD, of the University of Texas …
Current Therapies in Early-Stage HER2+ Breast CancerTargeted Oncology

all 3 news articles »

Continue reading

2017-03-13 Michael Zand NEWS
  • 1
  • …
  • 1,984
  • 1,985
  • 1,986
  • 1,987
  • 1,988
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Science Daily

Pain in the neck: Engineers use CRISPR technology to prevent tissue damage, resulting chronic pain
Science Daily
The team’s discovery was published in a new paper this month, “CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments,” in a special issue of Tissue Engineering.

and more »